AAD in Women and During Pregnancy
摘要
Cardiovascular Disease (CVD) is the leading cause of death in womenWomen worldwide. While pharmacological solutions for addressing CVD and its risk factors are advancing rapidly, there is a growing awareness of the persistent underrepresentation of womenWomen in clinical trials. Female sex is a risk factor of presenting Torsades des pointes (Tdp) in the context of an acquired long-QT.